RBCL (RBC Life Sciences) Gross Profit: $13.87 Mil (TTM As of Jun. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is RBC Life Sciences Gross Profit?

RBC Life Sciences RBCL +0.14% Gross Profit is $13.87 Mil as of Jun. 2017.

RBC Life Sciences's gross profit for the three months ended in Jun. 2017 was $3.24 Mil. RBC Life Sciences's gross profit for the trailing twelve months (TTM) ended in Jun. 2017 was $13.87 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. RBC Life Sciences's gross profit for the three months ended in Jun. 2017 was $3.24 Mil. RBC Life Sciences's Revenue for the three months ended in Jun. 2017 was $5.74 Mil. Therefore, RBC Life Sciences's Gross Margin % for the quarter that ended in Jun. 2017 was 56.45%.

RBC Life Sciences had a gross margin of 56.45% for the quarter that ended in Jun. 2017 => Durable competitive advantage


RBC Life Sciences  (OTCPK:RBCL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

RBC Life Sciences had a gross margin of 56.45% for the quarter that ended in Jun. 2017 => Durable competitive advantage


RBC Life Sciences Gross Profit Related Terms


RBC Life Sciences Gross Profit Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Gross Profit Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.63 12.01 15.64 13.46 13.61

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.32 3.90 3.68 3.04 3.24

RBCL vs SKVI, TISUQ, TECR: Gross Profit Comparison

For the Household & Personal Products subindustry, RBC Life Sciences's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RBC Life Sciences Gross Profit vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Gross Profit distribution charts can be found below:

* The bar in red indicates where RBC Life Sciences's Gross Profit falls into.



RBC Life Sciences Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

RBC Life Sciences's Gross Profit for the fiscal year that ended in Dec. 2016 is calculated as

Gross Profit (A: Dec. 2016 )=Revenue - Cost of Goods Sold
=25.773 - 12.159
=13.61

RBC Life Sciences's Gross Profit for the quarter that ended in Jun. 2017 is calculated as

Gross Profit (Q: Jun. 2017 )=Revenue - Cost of Goods Sold
=5.738 - 2.499
=3.24

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.87 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

RBC Life Sciences's Gross Margin % for the quarter that ended in Jun. 2017 is calculated as

Gross Margin % (Q: Jun. 2017 )=Gross Profit (Q: Jun. 2017 ) / Revenue (Q: Jun. 2017 )
=(Revenue - Cost of Goods Sold) / Revenue
=3.24 / 5.738
=56.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Profit →
What does a Gross Profit of $13.87 Mil mean?
RBC Life Sciences (RBCL) has a Gross Profit of $13.87 Mil as of Jun. 2017. Gross Profit equals net sales less total cost of goods sold. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Gross Profit too high?
RBC Life Sciences' current Gross Profit is $13.87 Mil.
How does RBC Life Sciences' Gross Profit compare to SKVI and TISUQ?
RBC Life Sciences' Gross Profit of $13.87 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Consumer Packaged Goods company?
A good Gross Profit depends on the Consumer Packaged Goods industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on RBC Life Sciences and its competitors. RBC Life Sciences's current Gross Profit is $13.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Gross Profit of $13.87 Mil. The current Gross Profit is $13.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Gross Profit is $13.87 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.